Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Innovex International (INVX) over the last 7 years, with Q2 2025 value amounting to $503000.0.

  • Innovex International's Asset Writedowns and Impairment fell 8571.83% to $503000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 269.73%. This contributed to the annual value of $3.5 million for FY2024, which is 122406.02% up from last year.
  • Latest data reveals that Innovex International reported Asset Writedowns and Impairment of $503000.0 as of Q2 2025, which was down 8571.83% from $2.9 million recorded in Q1 2025.
  • Over the past 5 years, Innovex International's Asset Writedowns and Impairment peaked at $3.5 million during Q2 2024, and registered a low of $266000.0 during Q3 2023.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $1.7 million (2025), whereas its average is $1.8 million.
  • Over the last 5 years, Innovex International's Asset Writedowns and Impairment had its largest YoY gain of 8571.83% in 2025, and its largest YoY loss of 8571.83% in 2025.
  • Innovex International's Asset Writedowns and Impairment (Quarter) stood at $266000.0 in 2023, then skyrocketed by 1224.06% to $3.5 million in 2024, then tumbled by 85.72% to $503000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $503000.0 for Q2 2025, versus $2.9 million for Q1 2025 and $3.5 million for Q2 2024.